Abstract
The pRb tumour suppressor protein has a central role in coordinating early cell cycle progression. An important level of control imposed on pRb occurs through post-translational modification, for example, phosphorylation. We describe here a new level of regulation on pRb, mediated through the targeted methylation of lysine residues, by the methyltransferase Set7/9. Set7/9 methylates the C-terminal region of pRb, both in vitro and in cells, and methylated pRb interacts with heterochromatin protein HP1. pRb methylation is required for pRb-dependent cell cycle arrest and transcriptional repression, as well as pRb-dependent differentiation. Our results indicate that methylation can influence the properties of pRb, and raise the interesting possibility that methylation modulates pRb tumour suppressor activity.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bandara LR, Adamczewski JP, Hunt T, La Thangue NB . (1991). Cyclin A and the retinoblastoma gene product complex with a common transcription factor. Nature 352: 249–251.
Chan HM, Krstic-Demonacos M, Smith L, Demonacos C, La Thangue NB . (2001). Acetylation control of the retinoblastoma tumour-suppressor protein. Nat Cell Biol 3: 667–674.
Chen TT, Wang JY . (2000). Establishment of irreversible growth arrest in myogenic differentiation requires the RB LXCXE-binding function. Mol Cell Biol 20: 5571–5580.
Chuikov S, Kurash JK, Wilson JR, Xiao B, Justin N, Ivanov GS et al. (2004). Regulation of p53 activity through lysine methylation. Nature 432: 353–360.
Clarke AR, Maandag ER, van Roon M, van der Lugt NM, van der Valk M, Hooper ML et al. (1992). Requirement for a functional Rb-1 gene in murine development. Nature 359: 328–330.
Classon M, Harlow E . (2002). The retinoblastoma tumour suppressor in development and cancer. Nat Rev Cancer 2: 910–917.
Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C et al. (1995). A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 92: 9363–9367.
Fischle W, Wang Y, Allis CD . (2003). Binary switches and modification cassettes in histone biology and beyond. Nature 425: 475–479.
Frolov MV, Dyson NJ . (2004). Molecular mechanisms of E2F-dependent activation and pRB-mediated repression. J Cell Sci 117: 2173–2181.
Fry CJ, Slansky JE, Farnham PJ . (1997). Position-dependent transcriptional regulation of the murine dihydrofolate reductase promoter by the E2F transactivation domain. Mol Cell Biol 17: 1966–1976.
Giacinti C, Giordano A . (2006). RB and cell cycle progression. Oncogene 25: 5220–5227.
Gu W, Schneider JW, Condorelli G, Kaushal S, Mahdavi V, Nadal-Ginard B . (1993). Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell 72: 309–324.
Hediger F, Gasser SM . (2006). Heterochromatin protein 1: don′t judge the book by its cover!. Curr Opin Genet Dev 16: 143–150.
Huh MS, Parker MH, Scime A, Parks R, Rudnicki MA. . (2004). Rb is required for progression through myogenic differentiation but not maintenance of terminal differentiation. J Cell Biol 166: 865–876.
Jacks T, Fazeli A, Schmitt EM, Bronson RT, Goodell MA, Weinberg RA . (1992). Effects of an Rb mutation in the mouse. Nature 359: 295–300.
Jenuwein T, Allis CD . (2001). Translating the histone code. Science 293: 1074–1080.
Kinkade R, Dasgupta P, Carie A, Pernazza D, Carless M, Pillai S et al. (2008). A small molecule disruptor of Rb/Raf-1 interaction inhibits cell proliferation, angiogenesis, and growth of human tumor xenografts in nude mice. Cancer Res 68: 3810–3818.
Kouskouti A, Scheer E, Staub A, Tora L, Talianidis I . (2004). Gene-specific modulation of TAF10 function by SET9-mediated methylation. Mol Cell 14: 175–182.
Kouzarides T . (2007). Chromatin modifications and their function. Cell 128: 693–705.
Kurash JK, Lei H, Shen Q, Marston WL, Granda BW, Fan H et al. (2008). Methylation of p53 by Set7/9 mediates p53 acetylation and activity in vivo. Mol Cell 29: 392–400.
Lee SW, Purushotham KR, Littlewood T, Evan G, Zelles T, Blazsek J et al. (1992). Down-regulation of cellular proto-oncogenes during inhibition of rat parotid acinar cell proliferation. Biochem Biophys Acta 1135: 115–122.
Lipinski MM, Jacks T . (1999). The retinoblastoma gene family in differentiation and development. Oncogene 18: 7873–7882.
Markham D, Munro S, Soloway J, O'Connor DP, La Thangue NB . (2006). DNA-damage-responsive acetylation of pRb regulates binding to E2F-1. EMBO Rep 7: 192–198.
Nguyen DX, Baglia LA, Huang SM, Baker CM, McCance DJ . (2004). Acetylation regulates the differentiation-specific functions of the retinoblastoma protein. EMBO J 23: 1609–1618.
Nielsen SJ, Schneider R, Bauer UM, Bannister AJ, Morrison A, O'Carroll D et al. (2001). Rb targets histone H3 methylation and HP1 to promoters. Nature 412: 561–565.
Novitch BG, Spicer DB, Kim PS, Cheung WL, Lassar AB . (1999). pRb is required for MEF2-dependent gene expression as well as cell-cycle arrest during skeletal muscle differentiation. Curr Biol 9: 449–459.
Santos-Rosa H, Schneider R, Bannister AJ, Sherriff J, Bernstein BE, Emre NC et al. (2002). Active genes are tri-methylated at K4 of histone H3. Nature 419: 407–411.
Sellers WR, Novitch BG, Miyake S, Heith A, Otterson GA, Kaye FJ et al. (1998). Stable binding to E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation, and suppress tumor cell growth. Genes Dev 12: 95–106.
Sherr CJ . (2000). The Pezcoller lecture: cancer cell cycles revisited. Cancer Res 60: 3689–3695.
Shew JY, Lin BT, Chen PL, Tseng BY, Yang-Feng TL, Lee WH . (1990). C-terminal truncation of the retinoblastoma gene product leads to functional inactivation. Proc Natl Acad Sci USA 87: 6–10.
Stevens C, La Thangue NB . (2003). E2F and cell cycle control: a double-edged sword. Arch Biochem Biophys 412: 157–169.
Subramanian K, Jia D, Kapoor-Vazirani P, Powell DR, Collins RE, Sharma D et al. (2008). Regulation of estrogen receptor alpha by the SET7 lysine methyltransferase. Mol Cell 30: 336–347.
Templeton DJ, Park SH, Lanier L, Weinberg RA . (1991). Nonfunctional mutants of the retinoblastoma protein are characterized by defects in phosphorylation, viral oncoprotein association, and nuclear tethering. Proc Natl Acad Sci USA 88: 3033–3037.
Thomas DM, Carty SA, Piscopo DM, Lee JS, Wang WF, Forrester WC et al. (2001). The retinoblastoma protein acts as a transcriptional coactivator required for osteogenic differentiation. Mol Cell 8: 303–316.
Thorburn AM, Walton PA, Feramisco JR . (1993). MyoD induced cell cycle arrest is associated with increased nuclear affinity of the Rb protein. Mol Biol Cell 4: 705–713.
van den Heuvel S, Dyson NJ . (2008). Conserved functions of the pRB and E2F families. Nat Rev Mol Cell Biol 9: 713–724.
Vandromme M, Chailleux C, Escaffit F, Trouche D . (2008). Binding of the retinoblastoma protein is not the determinant for stable repression of some E2F-regulated promoters in muscle cells. Mol Cancer Res 6: 418–425.
Wang J, Guo K, Wills KN, Walsh K . (1997). Rb functions to inhibit apoptosis during myocyte differentiation. Cancer Res 57: 351–354.
Weintraub SJ, Prater CA, Dean DC . (1992). Retinoblastoma protein switches the E2F site from positive to negative element. Nature 358: 259–261.
Weinberg RA . (1995). The retinoblastoma protein and cell cycle control. Cell 81: 323–330.
Wilson JR, Jing C, Walker PA, Martin SR, Howell SA, Blackburn GM et al. (2002). Crystal structure and functional analysis of the histone methyltransferase SET7/9. Cell 111: 105–115.
Xiao B, Wilson JR, Gamblin SJ . (2003). SET domains and histone methylation. Curr Opin Struct Biol 13: 699–705.
Zacksenhaus E, Jiang Z, Chung D, Marth JD, Phillips RA, Gallie BL . (1996). pRb controls proliferation, differentiation, and death of skeletal muscle cells and other lineages during embryogenesis. Genes Dev 10: 3051–3064.
Zalmas LP, Zhao X, Graham AL, Fisher R, Reilly C, Coutts AS et al. (2008). DNA damage response control of E2F-7 and E2F-8. EMBO Rep 9: 252–259.
Zamanian M, La Thangue NB . (1992). Adenovirus E1a prevents the retinoblastoma gene product from repressing the activity of a cellular transcription factor. EMBO J 11: 2603–2610.
Zhang Y, Reinberg D . (2001). Transcription regulation by histone methylation: interplay between different covalent modifications of the core histone tails. Genes Dev 15: 2343–2360.
Acknowledgements
We thank the CRUK, EU, LRF, MRC and AICR for supporting this work and R Williams for assistance in preparing the paper.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on the Oncogene website
Rights and permissions
About this article
Cite this article
Munro, S., Khaire, N., Inche, A. et al. Lysine methylation regulates the pRb tumour suppressor protein. Oncogene 29, 2357–2367 (2010). https://doi.org/10.1038/onc.2009.511
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2009.511
Keywords
This article is cited by
-
Protein post-translational modifications in the regulation of cancer hallmarks
Cancer Gene Therapy (2023)
-
Post-translational modifications on the retinoblastoma protein
Journal of Biomedical Science (2022)
-
Lysine methylation of transcription factors in cancer
Cell Death & Disease (2019)
-
Non-canonical functions of the RB protein in cancer
Nature Reviews Cancer (2018)
-
Biological processes and signal transduction pathways regulated by the protein methyltransferase SETD7 and their significance in cancer
Signal Transduction and Targeted Therapy (2018)